Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
Clinical trial NCT04751877 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04751877
- Sponsor
- Poitiers University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-17
- Primary completion
- 2024-06-18
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.